Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).

Annals of the rheumatic diseases - 1 Feb 2021

Spagnolo Paolo, Distler Oliver, Ryerson Christopher J, Tzouvelekis Argyris, Lee Joyce S, Bonella Francesco, Bouros Demosthenes, Hoffmann-Vold Anna-Maria, Crestani Bruno, Matteson Eric L

Abstract excerpt

Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct aetiologies, can manifest as a pulmonary complication of an underlying autoimmune and connective tissue disease (CTD-ILD), such as rheumatoid arthritis-ILD and systemic sclerosis (SSc-ILD). Patients with clinically distinct ILDs, whether CTD-related or not, can exhibit a pattern of common clinical disease behaviour (declining...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Connective Tissue Diseases
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibrosis

Share to Lung Diseases, Interstitial

Share to Phenotype

Share to Pulmonary Fibrosis

Source

Open in PubMed Open full text

Identifiers

PMID: 33037004
DOI: 10.1136/annrheumdis-2020-217230
PMCID: PMC7815631

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).PMID 33037004Read ↗

Progressive fibrotic interstitial lung disease.Semantic proximity Read ↗

Progressive fibrosing interstitial lung disease: treatable traits and therapeutic strategies.Semantic proximity Read ↗

When things go wrong: exploring possible mechanisms driving the progressive fibrosis phenotype in interstitial lung diseases.Semantic proximity Read ↗

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.Semantic proximity Read ↗

Recent advances in understanding idiopathic pulmonary fibrosisSemantic proximity Read ↗

An IPF-like disease course in disorders other than IPF: how can this be anticipated, recognized, and managed?Semantic proximity Read ↗

A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.Semantic proximity Read ↗

Immunological mechanisms and therapeutic approaches in pulmonary fibrosis.Semantic proximity Read ↗

A syndromic framework for progressive pulmonary fibrosis.Semantic proximity Read ↗

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis.Semantic proximity Read ↗

Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.Semantic proximity Read ↗

Pathogenesis and immune regulation of rheumatoid arthritis-associated interstitial lung disease: from basic research to clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.